Grantham, Mayo, Van Otterloo & Co (GMO)’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,700
Closed -$557K 842
2020
Q2
$557K Buy
+1,700
New +$358K ﹤0.01% 616

Other funds holding VAPO

Grantham, Mayo, Van Otterloo & Co (GMO)'s VAPO Position: Q3 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Vapotherm, Inc. Common Stock (VAPO) in Q3 2020, closing a stake of 1,700 shares — an estimated $557K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VAPO in Q2 2020 and held it in 1 quarter. The position peaked at $557K in Q2 2020. 114 funds tracked by Wall St. Rank hold VAPO as of Q3 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Vapotherm, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,700 Vapotherm, Inc. Common Stock shares in Q3 2020, an estimated $557K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Vapotherm, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Vapotherm, Inc. Common Stock position peaked at $557K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q3 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2020, filed 13 Nov 2020.